JanelsinsMC, KeslerSR, AhlesTA, MorrowGR: Prevalence, mechanisms, and management of cancer-related cognitive impairment. Int Rev Psychiatry Abingdon Engl, 2014; 26:102–113.
2.
JanelsinsMC, KohliS, MohileSG, et al.: An update on cancer- and chemotherapy-related cognitive dysfunction: Current status. Semin Oncol, 2011; 38:431–438.
3.
AhlesTA, SaykinAJ, FurstenbergCT, et al.: Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol Off J Am Soc Clin Oncol, 2002; 20:485–493.
4.
AhlesTA, RootJC, RyanEL: Cancer- and cancer treatment-associated cognitive change: An update on the state of the science. J Clin Oncol Off J Am Soc Clin Oncol, 2012; 30:3675–3686.
5.
JanelsinsMM: Cognitive complaints in survivors of breast cancer after chemotherapy compared with age-matched controls: An analysis from a nationwide, multicenter, prospective longitudinal study. J Clin Oncol, 2016. DOI:10.1200/JCO.2016.68.5826
6.
JimHSL, PhillipsKM, ChaitS, et al.: Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy. J Clin Oncol Off J Am Soc Clin Oncol, 2012; 30:3578–3587.
7.
HarrisSE, DearyIJ: The genetics of cognitive ability and cognitive ageing in healthy older people. Trends Cog Sci, 2011; 15:388–394.
VerstappenCC, HeimansJJ, et al.: Neurotoxic complications of chemotherapy in patients with cancer: Clinical signs and optimal management. Drugs, 2003; 63:1549–1563.
10.
WagnerL, SweetJ, ButtZ, et al.: Measuring patient self-reported cognitive function: Development of the functional assessment of cancer therapy—cognitive function instrument. J Support Oncol, 2009; 7:W32–W39.
11.
NasreddineZS, PhillipsNA, BédirianV, et al.: The montreal cognitive assessment, MoCA: A brief screening tool for mild cognitive impairment. J Am Geriatr Soc, 2005; 53:695–699.
12.
FolsteinMF, FolsteinSE, McHughPR: “Mini-mental state.” A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res, 1975; 12:189–19.
13.
BorsonS, ScanlanJM, ChenP, GanguliM: The Mini-Cog as a screen for dementia: Validation in a population-based sample. J Am Geriatr Soc, 2003; 51:1451–1454.
14.
KohliS, FisherSG, TraY, et al.: The effect of modafinil on cognitive function in breast cancer survivors. Cancer, 2009; 115:2605–2616.
15.
LundorffL, JonssonB, SjogrenP: Modafinil for attentional and psychomotor dysfunction in advanced cancer: A double-blind, randomised, cross-over trial. Palliat Med, 2009; 23:731–738.
16.
GagnonB, LowG, SchreierG: Methylphenidate hydrochloride improves cognitive function in patients with advanced cancer and hypoactive delirium: A prospective clinical study. J Psychiatry Neurosci, 2005; 30:100–107.
17.
BoeleFW, DouwL, de GrootM, et al.: The effect of modafinil on fatigue, cognitive functioning, and mood in primary brain tumor patients: A multicenter randomized controlled trial. Neuro-Oncol, 2013; 15:1420–1428.
18.
BlackhallL, PetroniG, ShuJ, et al.: A pilot study evaluating the safety and efficacy of modafinil for cancer-related fatigue. J Palliat Med, 2009; 12:433–439.
19.
Mar FanHG, ClemonsM, XuW, et al.: A randomised, placebo-controlled, double-blind trial of the effects of d-methylphenidate on fatigue and cognitive dysfunction in women undergoing adjuvant chemotherapy for breast cancer. Support Care Cancer, 2008; 16:577–583.
20.
CorreaDD, Kryza-LacombeM, BaserRE, et al.: Cognitive effects of donepezil therapy in patients with brain tumors: A pilot study. J Neurooncol, 2016; 127:313–319.
21.
ShawEG, RosdhalR, D'AgostinoRB, et al.: Phase II study of donepezil in irradiated brain tumor patients: Effect on cognitive function, mood, and quality of life. J Clin Oncol, 2006; 24:1415–1420.
22.
BrownPD, PughS, LaackNN, et al.: Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: A randomized, double-blind, placebo-controlled trial. Neuro-Oncology, 2013; 15:1429–1437.
23.
KuchererS, FergusonRJ: Cognitive behavioral therapy for cancer-related cognitive dysfunction. Curr Opin Support Palliat Care, 2017; 11:46–51.
24.
FergusonRJ, AhlesTA, SaykinAJ, et al.: Cognitive-behavioral management of chemotherapy-related cognitive change. Psychooncology, 2007; 16:772–777.
25.
FergusonRJ, SigmonST, PritchardAJ, LaBrieSLet al.: A randomized trial of videoconference-delivered cognitive behavioral therapy for survivors of breast cancer with self-reported cognitive dysfunction. Cancer, 2016; 122:1782–1791.
